Jason Xiang
Seminars
Tuesday 28th October 2025
Optimizing EGFR & KRAS G12D Targeting: Polymed’s Integrated Approach to PROTACs & DACs
2:30 pm
Download the Full Event Guide for Full Session Details.
- Designing high-potency EGFR and KRAS G12D degraders with optimized ADME and PK properties to enhance therapeutic performance
- Differentiating pharmacological profiles of PROTACs versus DACs to guide modality selection for specific oncogenic drivers
- Showcasing preclinical data demonstrating superior tumor kill and reduced toxicity achieved through Polymed’s tailored design strategy
